Stakeholders Interviewed Primary interviews for this study involved: Manufacturers and suppliers in the market value chain Distributors, channel partners, and integrators End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market) Industry experts, technology specialists, consultants, and regulatory professionals Senior executives (CEOs, CTOs, VPs, Directors) and product managers Interview Process Interviews were conducted via: Structured and semi-structured questionnaires Telephonic and video interactions Email correspondences Expert consultation sessions Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation
In senescent cells, however, p53 is actively suppressed by the transcription factor FOXO4
We look forward to working with policymakers, payers, clinicians and patient advocates to ensure that the promise of this announcement is realized in clinical practice including timely access, appropriate coverage, provider education, equitable care, and ongoing support for longterm outcomes. However Dr
GO:0042113